These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7351087

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
    Niell HB, Palmieri GM, Neely CL, McDonald MW.
    Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Urinary hydroxyproline levels in patients with prostatic carcinoma.
    Erol D, Adalar N, Güvençli S, Simşek F.
    Int Urol Nephrol; 1983 Oct; 15(3):267-70. PubMed ID: 6654633
    [Abstract] [Full Text] [Related]

  • 46. The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer.
    Niell HB, Neely CL, Palmieri GM, McDonald MW.
    Cancer; 1983 Oct 15; 52(8):1442-7. PubMed ID: 6616407
    [Abstract] [Full Text] [Related]

  • 47. Total and nondialyzable hydroxyproline excretion in Stage D2 prostate cancer.
    Hopkins SC, Palmieri GM, Niell HB, Moinuddin M, Soloway MS.
    Cancer; 1984 Jan 01; 53(1):117-21. PubMed ID: 6689994
    [Abstract] [Full Text] [Related]

  • 48. Hydroxyproline excretion in the detection of occult bone metastases from breast cancer.
    Rowse AD, Morrison MJ, Scott PH, Banks AJ, Roginski C.
    Oncology; 1982 Jan 01; 39(5):287-91. PubMed ID: 7099511
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M, Stepan JJ, Wilczek H, Formankova J, Moro L.
    Clin Chim Acta; 1995 Jan 31; 234(1-2):101-8. PubMed ID: 7758208
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Urinary excretion of hydroxyproline-containing peptides in man, rat, hamster, dog and monkey after feeding gelatin.
    Hueckel HJ, Rogers QR.
    Comp Biochem Physiol; 1970 Jan 01; 32(1):7-16. PubMed ID: 4984990
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Evaluation of clinical and humoral data in 148 patients with Piaget's bone disease].
    Fromm GA, Roca JF, Mautalén CA, Casco C.
    Medicina (B Aires); 1980 Jan 01; 40(6 Pt 1):635-42. PubMed ID: 22167694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.